Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder.
Phase of Trial: Phase III
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Milnacipran; Venlafaxine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 03 Jul 2012 Actual initiation date changed from 25 Aug 2006 to 21 Nov 2006 as reported by EudraCT.
- 03 Jul 2012 Planned End Date changed from 25 Feb 2008 to 21 Mar 2008 as reported by EudraCT.
- 26 May 2011 New trial record